IP Library Granted Patent US 9,181,531
Granted Patent B2
US 9,181,531 · App. 14/279,793 · Granted Nov 10, 2015

Process for purifying VLPs

Inventors: Juan Pedro Humberto Arhancet (Creve Coeur, MO); Juan P. Arhancet (Creve Coeur, MO); Kimberly Delaney (St. Louis, MO); Kathleen B. Hall (St. Louis, MO); Neena Summers (St. Charles, MO)
Assignee: APSE, LLC
C12N7/00A01N25/26A01N25/28C07K14/005C07K14/01C12N7/04C12N15/111C12N15/113C12N2310/121C12N2310/123C12N2310/128C12N2310/14C12N2310/16C12N2330/51C12N2795/18122C12N2795/18123C12N2795/18142
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,181,531
App. No.
14/279,793
Granted
Nov 10, 2015
Kind
B2
Abstract

Processes and compositions to produce, package, and purify virus like particles containing heterologous cargo molecules utilizing self assembling proteins and protease treatment coupled with simple precipitation and filtration methods are described.

Claims (19)

1. A process for purifying a quantity of virus-like particles (VLPs) consisting of Enterobacteriophage MS2 capsid proteins (SEQ ID NO.: 3) enclosing at least one heterologous cargo molecule, the process comprising: (a) obtaining a cell lysate comprising a plurality of the VLPs; (b) contacting the cell lysate with a protease for a time and under conditions sufficient to hydrolyze cell lysis products other than the VLPs to form a hydrolysate; and (c) isolating the VLPs from the hydrolysate.

2. The process according to claim 1 , wherein the protease is a peptide bond hydrolase category E.C. 3.4.

3. The process according to claim 1 , wherein the protease is selected from Proteinase K, Protease from Streptomyces griseus , Protease from Bacillus licheniformis , pepsin and papain.

4. The process according to claim 1 , wherein step (b) is performed for about 30 minutes.

5. The process according to claim 1 , wherein step (b) is performed at about 37° C.

6. The process according to claim 1 , wherein the time and condition for hydrolysis are sufficient for at least 60, at least 70, at least 80, or at least 90 of every 100 individual polypeptides present in the whole cell lysate but not enclosed by the capsids to be cleaved, while at least 60, at least 70, at least 80, or at least 90 of every 100 capsids present in the whole cell lysate before such hydrolysis remain intact following the hydrolysis.

7. The process according to claim 1 , wherein step (b) further comprises, contacting the cell lysate with at least one of the group consisting of a nuclease, an amylase and a lipase.

8. The process according to claim 1 , wherein step (c) comprises centrifuging the hydrolysate to obtain a precipitate comprising at least 90% by weight of the VLPs.

9. The process according to claim 1 , wherein step (c) comprises (i) performing a first precipitation of the hydrolysate with ammonium sulfate followed by a first centrifugation to obtain a first precipitate and a first supernatant; and (ii) performing a second precipitation on the first supernatant with ammonium sulfate followed by a second centrifugation to obtain a second precipitate, wherein the second precipitate comprises at least 90% by weight of the VLPs.

10. The process according to claim 1 , wherein step (c) comprises (i) performing a first precipitation of the hydrolysate with ethanol followed by a first centrifugation to obtain a first precipitate and a first supernatant; and (ii) performing a second precipitation on the first supernatant with ammonium sulfate followed by a second centrifugation to obtain a second precipitate, wherein the second precipitate comprises at least 90% by weight of the VLPs.

11. The process according to claim 1 , wherein the heterologous cargo molecule comprises an oligonucleotide linker coupling the heterologous cargo molecule and the VLP.

12. The process according to claim 11 , wherein the oligonucleotide linker is an oligoribonucleotide.

13. The process according to claim 1 , wherein the heterologous cargo molecule comprises an oligoribonucleotide selected from siRNA, shRNA, sshRNA, lshRNA and miRNA.

14. The process according to claim 1 , wherein the heterologous cargo molecule comprises an oligoribonucleotide comprising a ribozyme.

15. The process according to claim 1 , wherein the heterologous cargo molecule comprises a peptide or a polypeptide.

16. The process according to claim 1 , wherein the VLPs isolated from the hydrolsate comprise less than 4 grams of one or more cell lysis products for every 100 grams of capsid present in the composition, wherein the cell lysis products are selected from proteins, polypeptides, peptides and any combination thereof.

17. The process of claim 1 , wherein the quantity of virus-like particles (VLPs) enclosing at least one heterologous cargo molecule is at least ten milligrams.

18. The process of claim 1 , wherein the quantity of virus-like particles (VLPs) enclosing at least one heterologous cargo molecule is at least one gram.

19. The process of claim 1 , wherein the quantity of virus-like particles (VLPs) enclosing at least one heterologous cargo molecule is at least one hundred grams.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 18, 2023
From: APSE, INC.
To: RNAISSANCE AG LLC
Reel/Frame 062413/0561 →
CHANGE OF NAME Recorded Jan 26, 2022
From: APSE, LLC
To: APSE, INC.
Reel/Frame 058859/0522 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2016
From: ARHANCET, JUAN PEDRO HUMBERTO; DELANEY, KIMBERLY; HALL, KATHLEEN B.; SUMMERS, NEENA; ARHANCET, JUAN P.
To: APSE, LLC
Reel/Frame 039563/0629 →
Continuity (5)
Continuation 13725184 · Dec 21, 2012
Provisional Application 61607900 · Mar 7, 2012
Provisional Application 61578706 · Dec 21, 2011
Provisional Application 61661688 · Jun 19, 2012
Related Publication 20140302593A1 · Oct 9, 2014